BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30770506)

  • 21. Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.
    Emery P; van der Heijde D; Ostergaard M; Conaghan PG; Genovese MC; Keystone EC; Fleischmann R; Hsia EC; Xu W; Xu S; Rahman MU
    Ann Rheum Dis; 2011 Dec; 70(12):2126-30. PubMed ID: 21926186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative analysis of magnetic resonance imaging and high-resolution peripheral quantitative computed tomography of the hand for the detection of erosion repair in rheumatoid arthritis.
    Regensburger A; Rech J; Englbrecht M; Finzel S; Kraus S; Hecht K; Kleyer A; Haschka J; Hueber AJ; Cavallaro A; Schett G; Faustini F
    Rheumatology (Oxford); 2015 Sep; 54(9):1573-81. PubMed ID: 25832611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
    Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
    Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Course of Bone Marrow Edema in Early Undifferentiated Arthritis and Rheumatoid Arthritis: A Longitudinal Magnetic Resonance Imaging Study at Bone Level.
    Nieuwenhuis WP; van Steenbergen HW; Stomp W; Stijnen T; Huizinga TW; Bloem JL; van der Heijde D; Reijnierse M; van der Helm-van Mil AH
    Arthritis Rheumatol; 2016 May; 68(5):1080-8. PubMed ID: 26681086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.
    Beals C; Baumgartner R; Peterfy C; Balanescu A; Mirea G; Harabagiu A; Popa S; Cheng A; Feng D; Ashton E; DiCarlo J; Vallee MH; Dardzinski BJ
    PLoS One; 2017; 12(12):e0187397. PubMed ID: 29236711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
    Døhn UM; Ejbjerg B; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Ostergaard M
    Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating radiocarpal cartilage matrix changes 3-months after anti-TNF treatment for rheumatoid arthritis using MR T1ρ imaging.
    Ku E; Pedoia V; Tanaka M; Heilmeier U; Imboden J; Graf J; Link T; Li X
    J Magn Reson Imaging; 2017 May; 45(5):1514-1522. PubMed ID: 27661002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound Doppler score correlates with OMERACT RAMRIS bone marrow oedema and synovitis score in the wrist joint of patients with rheumatoid arthritis.
    Boesen M; Ellegaard K; Boesen L; Cimmino MA; Jensen PS; Terslev L; Torp-Pedersen S; Danneskiold-Samsøe B; Bliddal H
    Ultraschall Med; 2012 Dec; 33(7):E166-E172. PubMed ID: 21259184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
    Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
    Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study.
    Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P
    Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
    Gandjbakhch F; Foltz V; Mallet A; Bourgeois P; Fautrel B
    Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
    Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents.
    Ikeda K; Nakagomi D; Sanayama Y; Yamagata M; Okubo A; Iwamoto T; Kawashima H; Takahashi K; Nakajima H
    J Rheumatol; 2013 Dec; 40(12):1967-76. PubMed ID: 24187096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
    Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
    J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.
    Conaghan PG; Peterfy C; Olech E; Kaine J; Ridley D; Dicarlo J; Friedman J; Devenport J; Troum O
    Ann Rheum Dis; 2014 May; 73(5):810-6. PubMed ID: 24525910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
    Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
    Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging RAMRIS-SAFE score-A low-risk effective measure of rapid response to therapy in rheumatoid arthritis clinical trials.
    Bird P; Needham S; Spiers S; Hall S
    Int J Rheum Dis; 2023 Oct; 26(10):1960-1966. PubMed ID: 37530587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
    Finzel S; Kraus S; Figueiredo CP; Regensburger A; Kocijan R; Rech J; Schett G
    Ann Rheum Dis; 2019 Sep; 78(9):1186-1191. PubMed ID: 31142474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial.
    Baker JF; Ostergaard M; Emery P; Hsia EC; Lu J; Baker DG; Conaghan PG
    Ann Rheum Dis; 2014 Nov; 73(11):1968-74. PubMed ID: 23904470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.